Rainmed Medical : Revenue grew 41.3% as gross margin expanded and losses narrowed

H1 revenue rose 41.3% YoY and gross margin reached 63.2%, while shareholder-attributable loss narrowed to RMB22.0m. Growth was led by caFFR transducers, with cutting balloon sales commencing amid a challenging, tighter-regulation market.

Original document: Rainmed Medical Limited [2297] Earnings Release — Aug. 31 2026